The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
ben zha bei te he ji fei luo qi yong yu gao dan gu chun xue zheng
Author(s): 
Pages: 367
Year: Issue:  6
Journal: World Clinical Drugs

Keyword:  苯扎贝特高胆固醇血症吉非罗齐血清脂蛋白低密度胆固醇降血脂药血清胆固醇高密度胆固醇交叉试验安慰剂对照;
Abstract: <正> 作者以29例低密度胆固醇水平在180mg/dl以上的早期高胆固醇血症病人为对象,采用安慰剂对照、交叉试验,研究了降血脂药苯扎贝特(bezafibrate)和吉非罗齐(gemfibrozil)对血清脂蛋白水平的影响。受试者参试前预先排除甲状腺、肝、肾病患者,其中15例有冠心病或心肌梗塞症状存在。分别给予受试者苯扎贝特200mg一天3次,或吉非罗齐600mg一天2次,或安慰剂口服,每期8周,共4期。各期期末测定受试者血清胆固醇、甘油三酸酯和阿扑脂蛋白
Related Articles
No related articles found